3656 results for «392»

Filter By

3656 results

EAPCI-PCR Fellows Course - Closing ceremony

21 May 2019 – From EuroPCR 2019

Consult this session on the Closing ceremony of EAPCI-PCR Fellows Course to learn more about EAPCI certification exam, which gives credibility and professional legitimacy to an individual by demonstrating his/her competency on getting this certification and allows to identify qualified practitioners in interventional cardiology.

EAPCI-PCR Fellows Course - Closing ceremony

EAPCI-PCR Fellows Course - Opening Ceremony

20 May 2019 – From EuroPCR 2019

Consult this session to discover the EAPCI-PCR Fellows Course opening ceremony, introducing EAPCI, EuroPCR, Fellows course, and the EAPCI youngs. 

EAPCI-PCR Fellows Course - Opening Ceremony

Stent - Save A Life! 10th Anniversary Forum - Looking ahead – New candidates and new projects

20 May 2019 – From EuroPCR 2019

Consult this session from Stent - Save A Life! 10th Anniversary Forum to learn about the results of the primary PCI program in Aruba, the primary PCI Iranian project, and the STEMI Network Blueprint project.

Stent - Save A Life! 10th Anniversary Forum - Looking ahead – New candidates and new projects

How to choose material for a successful superficial femoral artery popliteal angioplasty?

22 May 2019 – From EuroPCR 2019

Consult this session to learn all about lesion specific strategies in complex superficial femoral artery obstructive disease, the impact of lesion length and calcification on treatment choice, and how to define treatment algorithm for drug coated balloons and stent devices.

How to choose material

Critical limb ischaemia antegrade below-the-knee angioplasty - LIVE Case

22 May 2019 – From EuroPCR 2019

Consult this session to learn all about first intention anterograde access, the currently available wires and how to use microcatheters and low-profile balloons.

Critical limb ischaemia antegrade below-the-knee angioplasty

Closing remarks - PCR Innovators Day 2019

20 May 2019 – From PCR Innovators Day 2019

Consult this session to discover the closing remarks on PCR Innovators Day 2019, regarding the presentations of innovative technologies: Cavis Technologies' WireCath, CorFlow Therapeutics, Procerion and GENOSS.

Closing remarks - PCR

EAPCI General Assembly

22 May 2019 – From EuroPCR 2019

Consult this session to discover the EAPCI General Assembly's slides, presented during EuroPCR 2019. Learn more about the different committees and the grants programme.

EAPCI General Assembly

TAVI for aortic valve-in-valve - LIVE Case

22 May 2019 – From EuroPCR 2019

Consult this session to discover an exciting case, live transmitted during EuroPCR 2019: it will take you to a whole new territory of TAVI, focusing on the generation of bioprosthetic heart valves issues and the transcatheter solutions which are emerging as an optimal approach to this...

TAVI for aortic valve-in-valve

Why hypertension is a major unresolved problem

02 Oct 2024

Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.

Sofie Brouwers

Author

Sofie Brouwers
Why hypertension is a major unresolved problem

Which AF patients may benefit from LAA closure?

02 Jul 2026

Martin Bergmann reviews the evolving evidence for LAAC, examining how recent landmark trials such as OPTION, CLOSURE‑AF and CHAMPION‑AF are reshaping patient selection and expanding the role of LAAC across a broader spectrum of patients with atrial fibrillation.

Martin W. Bergmann

Author

Martin W. Bergmann
Which AF patients may benefit from LAA Closure?

TRISCEND II: Two-year outcomes of transcatheter tricuspid valve replacement for severe tricuspid regurgitation

31 Mar 2026

Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.

Jonathan Curio

Author

Jonathan Curio
TRISCEND II: Two-Year Outcomes Of Transcatheter Tricuspid Valve Replacement For Severe Tricuspid Regurgitation

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

From PROTECT-AF to CHAMPION-AF: Where do we stand today?

01 Jul 2026

In this article, Jens Erik Nielsen-Kudsk reviews the evolution of left atrial appendage closure, from early trials such as PROTECT‑AF to recent evidence including CHAMPION‑AF, and discusses its expanding role in stroke prevention for atrial fibrillation.

Jens-Erik-Nielsen-Kudsk

Author

Jens Erik Nielsen-Kudsk
From PROTECT-AF to CHAMPION-AF: Where do we stand today?

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

Evidence base: A description of the key, so far published, studies in the space of drug coated balloons

23 Jan 2025

Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.

Author

Hector Garcia-Garcia
Jorge Sanz Sanchez

Author

Jorge Sanz-Sanchez
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?